Clinical Trial Update: Adjuvant High-Dose Thiotepa and Stem Cell Rescue Associated With Conventional Chemotherapy in Relapsed Osteosarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating adjuvant high-dose thiotepa with stem cell rescue alongside conventional chemotherapy in relapsed osteosarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• thiotepa (high-dose adjuvant) (thiotepa)

Snippet

Sponsor: Centre Leon Berard | Conditions: Osteosarcoma | Phase 2 | Status: COMPLETED